Bio-Rad Laboratories (NYSE:BIO.B) Issues Earnings Results

Bio-Rad Laboratories (NYSE:BIO.B) issued its quarterly earnings results on Thursday. The company reported $2.90 earnings per share (EPS) for the quarter, Zacks reports. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%.

Bio-Rad Laboratories Price Performance

Shares of Bio-Rad Laboratories stock opened at $312.05 on Friday. Bio-Rad Laboratories has a 52-week low of $279.91 and a 52-week high of $359.22. The company has a 50 day moving average of $337.86 and a 200 day moving average of $332.76. The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16. The company has a market capitalization of $8.74 billion, a P/E ratio of -11.42 and a beta of 0.73.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.